project id: TCGA-UVM; case submitter id: TCGA-VD-AA8R; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.93; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.7; rna integrity number: 9.4; age at index: 78; days to birth: -28841; ethnicity: not reported; gender: female; race: not reported; vital status: Alive; year of birth: 1935; age at diagnosis: 28841; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 6.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 90; days to sample procurement: 0; initial weight: 20.0; sample id: 30822e80-8ef8-4ac9-af5d-304aa7f8c1dd; sample submitter id: TCGA-VD-AA8R-01A; portion id: f6868863-9cdc-41ed-9a24-c5ac7cf94dc8; portion submitter id: TCGA-VD-AA8R-01A-11; slide id: b2072ea5-0af2-433c-b5f2-81125ace37c2; slide submitter id: TCGA-VD-AA8R-01Z-00-DX1; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 3.0; percent normal cells: 5.0; percent stromal cells: 20.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0; section location: TOP;